Bristol-Myers Profit Beats Estimates on Plavix, HIV Treatments - Bloomberg
Thu, 22 Jul 2010 11:48:49 GMT+00:00
- Myers Profit Beats Estimates on Plavix, HIV Treatments Bloomberg Bristol - Myers Squibb Co.'s second- quarter earnings beat analysts' estimates as the drugmaker reduced costs and boosted ... Lower expenses boost Bristol - Myers profit MarketWatch Bristol - Myers posts 6 percent drop in 2Q profit The Associated Press Bristol - Myers keeps outlook as profit drops MarketWatch The Associated Press  - Reuters  - Comtex Smartrend

Health Highlights: July 12, 2010 - BusinessWeek
Mon, 12 Jul 2010 17:29:37 GMT+00:00
BusinessWeek Drug giant Bristol - Myers Squibb on Monday said it is recalling eight lots of the widely used blood thinner Coumadin because the amount of active ingredient ... Miller Tabak Likes Bristol Myers Squibb (BMY), Novartis (NVS) And Merck (MRK) Benzinga Bristol - Myers Squibb recalls Coumadin (warfarin) blister packs Flesh and Stone Earnings Look Ahead: In 13 days, Bristol - Myers Squibb Releases Its Quarterly ... Investor's Business Daily ConsumerReports.org (blog)  - AboutLawsuits.com  - eMaxHealth

SADIF Analytics releases new summary due diligence report for Bristol Myers ... - PR-inside.com (press release)
Mon, 26 Jul 2010 07:56:52 GMT+00:00
... PR-inside.com (press release) 2010-07-26 09:53:29 - SADIF-Investment Analytics has applied its StockMarks stock-rating system to Bristol Myers Squibb Co. and produced a report, ...

Drug Trials Test Bold Plan to Slow Alzheimer's - New York Times
Sat, 17 Jul 2010 04:50:30 GMT+00:00
New York Times That is the ultimate goal for the drug in the study Mrs. Maldonado wants to enter, sponsored by Bristol - Myers Squibb. The company is, for the first time, ... Drug Trials Test Slowing Alzheimer's Plan Visit Bulgaria

Earnings Preview: Pfizer to report 2Q earnings - BusinessWeek
Sat, 31 Jul 2010 04:31:30 GMT+00:00
BusinessWeek Pfizer is developing apixaban with Bristol - Myers Squibb Co. Pfizer, a Dow component, likely will discuss its progress in increasing sales in emerging ...

Buy Exelixis Now. Wait, Maybe Buy These Instead. - Motley Fool
Wed, 28 Jul 2010 17:33:47 GMT+00:00
Motley Fool Shares took a hit when Bristol - Myers Squibb (NYSE: BMY) terminated its partnership with Exelixis on the cancer drug XL184 -- not a good sign for a product ...

3 Biotechs on Your Radar Screen - msnbc.com
Wed, 28 Jul 2010 14:16:12 GMT+00:00
msnbc.com If the drug proves viable, it will compete with Cytoxan, a generic drug that is currently manufactured by Bristol - Myers Squibb. Right now, perifosine is in ... 3 Biotechs on Your Radar Screen Motley Fool

Baxter, Human Genome gain in afternoon trading - MarketWatch
Thu, 22 Jul 2010 14:31:56 GMT+00:00
MarketWatch See Bristol earnings story. Bristol - Myers also confirmed its previously-issued 2010 forecast of earnings in a range of $1.84 to $1.94 a share, and adjusted ...

BEFORE THE BELL: US Stock Futures Rally On Strong European Data - Wall Street Journal
Fri, 23 Jul 2010 03:44:01 GMT+00:00
Wall Street Journal Drug-maker Bristol - Myers Squibb Co.'s (BMY) second-quarter profit slipped a less-than-feared 5.7% on lower margins, though revenue growth didn't meet ... US Stock Futures Pare Gains After Jobless Data; DJIA Up 95 Wall Street Journal US Stocks Surge On Strong Earnings, European Economic Data MarketWatch

AIDS Healthcare Foundation Bans BMS Drug Reps from Its Clinics - MarketWatch (press release)
Mon, 26 Jul 2010 18:36:38 GMT+00:00
MarketWatch (press release) Today AIDS Healthcare Foundation (AHF) announced that it has banned pharmaceutical sales representatives from Bristol - Myers Squibb (BMS) from calling on ...

Bristol-Myers Recalls Coumadin Blister Pack Samples - Avon Lake Ledger
Wed, 07 Jul 2010 00:04:41 GMT+00:00
- Myers Recalls Coumadin Blister Pack Samples Avon Lake Ledger These were intended for doctors or hospitals to give out to their patients as trial samples. They are being recalled because of the possibility that some of ...

LOOK FOR SHARES OF BRISTOL-MYERS SQUIBB TO PULLBACK AFTER YESTERDAY'S 1.40 ... - Zacks.com
Wed, 28 Jul 2010 12:48:07 GMT+00:00
- myers squibb to pullback after yesterday'S 1.40 ... Zacks.com Jul 28, 2010 (SmarTrend(R) News Watch via COMTEX) -- Bristol - Myers Squibb (NYSE:BMY) traded in a range yesterday that spanned from a low of $24.84 to a high ...

AT&T Net Up; Philip Morris Sales Rise - 123Jump.com
Thu, 22 Jul 2010 21:06:51 GMT+00:00
123Jump.com Bristol - Myers Squibb Company (BMY), the drugmaker reported second quarter revenues rose 2% to $4.77 billion from $4.67 billion a year ago. ... CA, Netflix Decline; AutoNation, eBay Rise Ticker Magazine

Earnings Roundup: UPS, BMY, CAL, NUE, PM, AN, NYT - NewsyStocks.com
Thu, 22 Jul 2010 14:37:48 GMT+00:00
NewsyStocks.com Bristol - Myers Squibb Co. (NYSE: BMY) reported Thursday that its second-quarter profit dropped 6% to $927 million, or 53 cents a share, from $983 million, ...

Which antiplatelet therapy is best for patients on PPIs? New trial to the rescue - Cardiovascular Business
Wed, 28 Jul 2010 18:01:53 GMT+00:00
Cardiovascular Business ... Daiichi-Sankyo/Eli Lilly) or a double dose of clopidogrel (Plavix, Bristol - Myers Squibb/Sanofi Aventis), in coronary artery disease patients who are ...

AIDS 2010: promising developments for novel HIV agents and strategies - Trading Markets (press release)
Tue, 27 Jul 2010 17:11:05 GMT+00:00
Trading Markets (press release) The studies compared the safety and efficacy of rilpivirine to Sustiva (efavirenz; Bristol - Myers Squibb) in combination with either Truvada or Epzicom ...

EPS growth in Q2 2010 - MarketWatch (press release)
Thu, 29 Jul 2010 12:12:20 GMT+00:00
MarketWatch (press release) In the US, Plavix(R) delivered sales of euro 1179 million (net sales consolidated by Bristol - Myers Squibb), which represented 7.2% growth. ...

Jim Cornelius - 2009 CEO Pay - FiercePharma
Wed, 07 Jul 2010 12:01:32 GMT+00:00
FiercePharma Details: Bristol - Myers Squibb CEO Jim Cornelius, who officially retired May 4, didn't fare too badly during his last full year on the job. ...

Sales of Drugs From Multinational Corporations Will Represent 92 Percent of ... - PR Newswire (press release)
Thu, 29 Jul 2010 13:02:34 GMT+00:00
PR Newswire (press release) For example, Bristol - Myers Squibb's Bristaxol, for which paclitaxel generics have been available for several years in Mexico, still enjoys almost 80 percent ...

B-MS posts strong sales again for Plavix - Pharma Times
Fri, 23 Jul 2010 06:23:16 GMT+00:00
Pharma Times Bristol - Myers Squibb's second-quarter financials have revealed continuing strong sales of the bloodthinner Plavix and its virolology franchise. ...